Plexus Corp. (NASDAQ:PLXS) CEO Todd P. Kelsey Sells 4,248 Shares

Plexus Corp. (NASDAQ:PLXS) CEO Todd P. Kelsey sold 4,248 shares of the company’s stock in a transaction on Wednesday, May 1st. The shares were sold at an average price of $101.67, for a total transaction of $431,894.16. Following the completion of the transaction, the chief executive officer now owns 108,562 shares of the company’s stock, valued at approximately $11,037,498.54. The sale was disclosed in a filing with the SEC, which is available at this link.

Plexus Stock Up 1.1 %

PLXS opened at $103.39 on Friday. Plexus Corp. has a 52 week low of $83.84 and a 52 week high of $114.06. The business has a 50 day moving average price of $95.10 and a two-hundred day moving average price of $98.62. The company has a quick ratio of 0.64, a current ratio of 1.51 and a debt-to-equity ratio of 0.15. The company has a market cap of $2.85 billion, a PE ratio of 28.56 and a beta of 1.00.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings results on Wednesday, April 24th. The technology company reported $0.94 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.07. The firm had revenue of $966.90 million during the quarter, compared to the consensus estimate of $950.75 million. Plexus had a return on equity of 10.77% and a net margin of 2.54%. The company’s revenue for the quarter was down 9.7% on a year-over-year basis. During the same period last year, the company earned $1.45 earnings per share. As a group, research analysts anticipate that Plexus Corp. will post 3.61 EPS for the current year.

Analysts Set New Price Targets

PLXS has been the subject of several research analyst reports. TheStreet downgraded shares of Plexus from a “b” rating to a “c+” rating in a research note on Tuesday, February 13th. Needham & Company LLC upped their target price on Plexus from $107.00 to $114.00 and gave the company a “buy” rating in a research report on Friday, April 26th. Benchmark reaffirmed a “buy” rating and set a $110.00 price target on shares of Plexus in a research report on Wednesday, January 17th. Sidoti cut Plexus from a “buy” rating to a “neutral” rating and set a $112.00 price objective for the company. in a research note on Tuesday, January 9th. Finally, Stifel Nicolaus raised their target price on shares of Plexus from $90.00 to $95.00 and gave the stock a “hold” rating in a research report on Friday, April 26th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $107.75.

Institutional Trading of Plexus

Hedge funds and other institutional investors have recently made changes to their positions in the company. Qube Research & Technologies Ltd lifted its position in Plexus by 93.7% in the third quarter. Qube Research & Technologies Ltd now owns 22,691 shares of the technology company’s stock valued at $2,110,000 after purchasing an additional 10,975 shares during the period. Avior Wealth Management LLC boosted its stake in shares of Plexus by 115.2% in the fourth quarter. Avior Wealth Management LLC now owns 2,118 shares of the technology company’s stock valued at $229,000 after buying an additional 1,134 shares in the last quarter. Vanguard Group Inc. grew its holdings in Plexus by 1.4% during the third quarter. Vanguard Group Inc. now owns 3,453,940 shares of the technology company’s stock worth $321,147,000 after acquiring an additional 47,762 shares during the period. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Plexus in the third quarter worth $715,000. Finally, First Eagle Investment Management LLC acquired a new stake in Plexus in the third quarter valued at $5,865,000. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.